Fidelity Investments’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $96K | Buy |
10,410
+114
| +1% | +$1.05K | ﹤0.01% | 3622 |
|
|
2025
Q1 | $88.3K | Buy |
10,296
+1,368
| +15% | +$11.7K | ﹤0.01% | 3612 |
|
|
2024
Q4 | $95.9K | Buy |
8,928
+526
| +6% | +$5.65K | ﹤0.01% | 3561 |
|
|
2024
Q3 | $47.7K | Sell |
8,402
-4,884
| -37% | -$27.7K | ﹤0.01% | 3796 |
|
|
2024
Q2 | $56.1K | Buy |
13,286
+11,541
| +661% | +$48.7K | ﹤0.01% | 3553 |
|
|
2024
Q1 | $8.88K | Sell |
1,745
-7,502
| -81% | -$38.2K | ﹤0.01% | 4320 |
|
|
2023
Q4 | $86.1K | Buy |
9,247
+8,396
| +987% | +$78.2K | ﹤0.01% | 3273 |
|
|
2023
Q3 | $5.57K | Sell |
851
-1,111
| -57% | -$7.28K | ﹤0.01% | 4300 |
|
|
2023
Q2 | $16K | Buy |
1,962
+562
| +40% | +$4.57K | ﹤0.01% | 3964 |
|
|
2023
Q1 | $12K | Buy |
1,400
+338
| +32% | +$2.9K | ﹤0.01% | 4057 |
|
|
2022
Q4 | $9.84K | Sell |
1,062
-637
| -37% | -$5.9K | ﹤0.01% | 4020 |
|
|
2022
Q3 | $17K | Sell |
1,699
-44,346
| -96% | -$444K | ﹤0.01% | 3904 |
|
|
2022
Q2 | $461K | Buy |
46,045
+298
| +0.7% | +$2.98K | ﹤0.01% | 2873 |
|
|
2022
Q1 | $563K | Buy |
45,747
+45,710
| +123,541% | +$563K | ﹤0.01% | 2948 |
|
|
2021
Q4 | $1K | Sell |
37
-2,500
| -99% | -$67.6K | ﹤0.01% | 4093 |
|
|
2021
Q3 | $46K | Buy |
2,537
+2,492
| +5,538% | +$45.2K | ﹤0.01% | 3231 |
|
|
2021
Q2 | $1K | Buy |
+45
| New | +$1K | ﹤0.01% | 3994 |
|